Pandora's Basket? Overenthusiasm May Be Side Effect Of Biomarker-Driven Trials
Executive Summary
Sponsors stress that basket trials are designed to find signals of activity that will be followed up with randomized, controlled studies, but NEJM editorial wonders if off-label prescribing will circumvent those intentions.